Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Xi-Tao WANG"'
Autor:
Yang Dong, Lin Hao, Kun Fang, Xiao-xiao Han, Hui Yu, Jian-jun Zhang, Long-jun Cai, Tao Fan, Wen-da Zhang, Kun Pang, Wei-ming Ma, Xi-tao Wang, Cong-hui Han
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Solanum nigrum L. decoction has been used as a folklore medicine in China to prevent the postoperative recurrence of bladder cancer (BC). However, there are no previous pharmacological studies on the protective mechanisms of this
Externí odkaz:
https://doaj.org/article/00f32381367940b1a6c0680f81b81456
Autor:
Tao LI, Zhong-jun LENG, Xi-tao WANG, Shi-fang WANG, Su-qing ZHANG, Yuan-sheng YANG, Ji-xue ZHOU
Publikováno v:
Transactions of Nonferrous Metals Society of China. 32:3950-3962
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d4b1d7ac9baf2f47b97c76c9f8a2c2b
https://doi.org/10.1016/s1003-6326(22)66069-2
https://doi.org/10.1016/s1003-6326(22)66069-2
Autor:
Kent Thudium, Mark Selby, Julie A. Zorn, Gregory Rak, Xi-Tao Wang, Roderick Todd Bunch, Jason M. Hogan, Pavel Strop, Alan J. Korman
Publikováno v:
Cancer Immunology Research. 10:1175-1189
Novel therapeutic approaches combining immune checkpoint inhibitors are needed to improve clinical outcomes for patients with cancer. Lymphocyte-activation gene 3 (LAG-3) is an immune checkpoint molecule that inhibits T-cell activity and antitumor im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::998abd82ce6e0d18fac052d7e8514843
https://doi.org/10.1158/2326-6066.cir-22-0057
https://doi.org/10.1158/2326-6066.cir-22-0057
Autor:
Alan J. Korman, Pavel Strop, Jason M. Hogan, Roderick Todd Bunch, Xi-Tao Wang, Gregory Rak, Julie A. Zorn, Mark Selby, Kent Thudium
Supplementary Data from Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5105aa7f014ffe63c49424bcb78d4df9
https://doi.org/10.1158/2326-6066.22545668
https://doi.org/10.1158/2326-6066.22545668
Autor:
Alan J. Korman, Pavel Strop, Jason M. Hogan, Roderick Todd Bunch, Xi-Tao Wang, Gregory Rak, Julie A. Zorn, Mark Selby, Kent Thudium
Novel therapeutic approaches combining immune-checkpoint inhibitors are needed to improve clinical outcomes for patients with cancer. Lymphocyte-activation gene 3 (LAG-3) is an immune-checkpoint molecule that inhibits T-cell activity and antitumor im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61f873646c4378fa6cbb3fc2c62d7017
https://doi.org/10.1158/2326-6066.c.6551000.v1
https://doi.org/10.1158/2326-6066.c.6551000.v1
Autor:
Alan J. Korman, Mark J. Selby, Diann Blanset, R. Todd Bunch, Heidi Leblanc, Neysa Garner, Susan Wong, Sujata Singh, Mohan Srinivasan, Michelle Kuhne, Yi Wu, Candy Garcia, Diane Feingersh, Haichun Huang, Xi-Tao Wang, Minhua Han, Kent B. Thudium, Changyu Wang
PDF file - 25K, Figure S5. Effect of nivolumab on CD8+ T-cell subsets and DCs in PBMCs from nivolumab-treated cynomolgus monkeys.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3afeb590b18bc2205b3661f639ca33c
https://doi.org/10.1158/2326-6066.22537295
https://doi.org/10.1158/2326-6066.22537295
Autor:
Alan J. Korman, Mark J. Selby, Diann Blanset, R. Todd Bunch, Heidi Leblanc, Neysa Garner, Susan Wong, Sujata Singh, Mohan Srinivasan, Michelle Kuhne, Yi Wu, Candy Garcia, Diane Feingersh, Haichun Huang, Xi-Tao Wang, Minhua Han, Kent B. Thudium, Changyu Wang
PDF file - 376K, Figure S2. Epitope of nivolumab on human PD-1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b853d4530e61228723451974fc3c28ae
https://doi.org/10.1158/2326-6066.22537304.v1
https://doi.org/10.1158/2326-6066.22537304.v1
Autor:
Alan J. Korman, Mark J. Selby, Diann Blanset, R. Todd Bunch, Heidi Leblanc, Neysa Garner, Susan Wong, Sujata Singh, Mohan Srinivasan, Michelle Kuhne, Yi Wu, Candy Garcia, Diane Feingersh, Haichun Huang, Xi-Tao Wang, Minhua Han, Kent B. Thudium, Changyu Wang
PDF file - 400K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77e844640ae1ffeb1fc6f84395d28dbf
https://doi.org/10.1158/2326-6066.22537292
https://doi.org/10.1158/2326-6066.22537292
Autor:
Alan J. Korman, Mark J. Selby, Diann Blanset, R. Todd Bunch, Heidi Leblanc, Neysa Garner, Susan Wong, Sujata Singh, Mohan Srinivasan, Michelle Kuhne, Yi Wu, Candy Garcia, Diane Feingersh, Haichun Huang, Xi-Tao Wang, Minhua Han, Kent B. Thudium, Changyu Wang
PDF file - 22K, Figure S3. Nivolumab inhibits PD-1 interaction with PD-L1 and PD-L2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::171e64e5c6eda8b06e46db9ba0ec0274
https://doi.org/10.1158/2326-6066.22537301.v1
https://doi.org/10.1158/2326-6066.22537301.v1
Autor:
David A. Barbie, Matthew G. Oser, Ellis L. Reinherz, Scott Rodig, Robin Edwards, Evisa Gjini, Pasi A. Jänne, Kathleen Pfaff, Michael Y. Tolstorukov, Lynette M. Sholl, Fangxin Hong, Benjamin Chen, Xi-Tao Wang, Ana Lako, Eliezer M. Van Allen, Mark M. Awad, Cloud P. Paweletz, Prafulla C. Gokhale, Brendan Reardon, Hideo Watanabe, Maya Fridrikh, Aoi Akitsu, Shunsuke Kitajima, Israel Cañadas, Takahiko Murayama, Alison D. Santucci, Victor Quadros, Andrew Portell, Patrick H. Lizotte, Luke J. Taus, Michael J. Poitras, Jonathan S. Duke-Cohan, Bruce B. Reinhold, Saemi Han, Brandon Piel, Tran C. Thai, Deli Hong, Marco Campisi, Maria Saigí, Amir Vajdi, Jacquelyn O. Wolff, Erik H. Knelson, Navin R. Mahadevan
Small cell lung carcinoma (SCLC) is highly mutated, yet durable response to immune checkpoint blockade (ICB) is rare. SCLC also exhibits cellular plasticity, which could influence its immunobiology. Here we discover that a distinct subset of SCLC uni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4647caa0d1c61ca9a140b00973df6824
https://doi.org/10.1158/2159-8290.c.6549244.v1
https://doi.org/10.1158/2159-8290.c.6549244.v1